Does payer coverage of genomic testing drive utilization? That is the question The Personalized Medicine Coalition (“PMC”) asked and answered in its recent report “Understanding Genomic Testing ...

Ann Arbor, Michigan – Visiun announced today the addition of test utilization to the cloud-based version of its leading laboratory analytics system, Performance Insight™. Visiun’s test utilization ...

Medicare-eligible patients with cutaneous squamous cell carcinoma (cSCC) could save on health care costs by utilizing the 40-gene expression profile (40-GEP) to guide treatment decisions. Patients ...

Cost display and cost charge induce different test ordering behavior depending on the healthcare setting. Objectives: To study the effects on the number of laboratory tests ordered after introduction ...

Laboratory tests represent the single highest-volume medical intervention, with over 7 billion tests performed every year in the U.S. Although results from diagnostic testing are estimated to ...

Laboratories use the same laboratory equipment they invested in for COVID testing to perform PGx testing. With COVID testing reimbursement dropping, many laboratorians are considering implementing PGx ...

Genomic Alterations as Potential Therapeutic Targets in Extramammary Paget’s Disease of the Vulva The routine use of large next-generation sequencing (NGS) pan-cancer panels is required to identify ...

Does health information exchange actually have an effect on utilization of healthcare services? That's a question the University of Colorado Health Sciences Center will attempt to answer by analyzing ...

Indianapolis-based Hc1.com, whose software helps health care organizations interpret data to personalize care and control costs, has reached a breakthrough deal with lab-testing giant Quest ...

SANTA ROSA, Calif.--(BUSINESS WIRE)--Keysight Technologies, Inc. (NYSE: KEYS), a leading technology company that helps enterprises, service providers, and governments accelerate innovation to connect ...

Biomarker testing surveys specific disease-associated molecules to predict treatment response and disease progression; however its use has complicated the diagnosis of non-small-cell lung cancer ...

Ann Arbor, Michigan – Visiun announced today the addition of test utilization to the cloud-based version of its leading laboratory analytics system, Performance Insight™. Visiun's test utilization ...